<DOC>
	<DOC>NCT02960451</DOC>
	<brief_summary>The purpose of this study is to determine whether specialty care is superior to usual care in the treatment of patients at clinical high risk for psychosis.</brief_summary>
	<brief_title>PRIME vs Usual Care for Clinical High Risk</brief_title>
	<detailed_description>This study is a randomized clinical effectiveness trial for patients at clinical high risk for psychosis that compares two treatments: 1) specialty care delivered in a specialized clinical for patients at clinical high risk for psychosis versus 2) treatment as usual in the community.</detailed_description>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<criteria>Subjects must meet all of the following: 1. Male or female between 12 and 30 years old. 2. Understand and sign an informed consent (or assent for minors) document in English. 3. Meet diagnostic criteria for prodromal syndrome as per COPS criteria. Subjects must not meet any of the following: 1. Diagnosis of current or lifetime Axis I psychotic disorder, including mood disorder with psychotic symptoms. 2. Impaired intellectual functioning (fullscale IQ&lt;70). However, those with an IQ in the 6569 range will not be excluded if they score &gt;75 on the WRAT Reading. 3. Past or current history of a clinically significant central nervous system disorder that may contribute to prodromal symptoms or confound their assessment. 4. Alcohol or substance dependence in the past 6 months.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>prodrome</keyword>
	<keyword>cognitive behavioral therapy</keyword>
	<keyword>family focused therapy</keyword>
</DOC>